Cannabinoid Encyclopedia

Focused research review

CB1 receptor neurobehavioral/metabolic: what the research says

What evidence connects CB1 receptor biology with neurobehavioral, reward, appetite, metabolic, pain, or cognition-related mechanisms?

Updated July 2026 24 research sources Mostly early-stage research

The short answer

What is the bottom line?

Research has examined CB1 receptor neurobehavioral/metabolic. This page brings together 5 human-study sources, 14 research reviews, and 5 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about CB1 receptor neurobehavioral/metabolic.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on CB1 receptor neurobehavioral/metabolic covers CB1; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about CB1 receptor neurobehavioral/metabolic

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Too limited for a firm answer

CB1

This part of the literature focuses on CB1. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

5 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

14 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

5 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on CB1 receptor neurobehavioral/metabolic is not one kind of study. This source set includes 13 narrative or expert reviews, 9 animal studies, 1 clinical study in people, and 1 systematic review or meta-analysis. 3

The recorded populations or models include people or patients (8 sources), animal models (6 sources), and cells or tissue models (3 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is cB1 neurobehavioral, appetite, metabolic, pain, cognition, or synaptic mechanisms (24 sources). Closely related outcome names can still describe different measurements. 5

The CB1 receptor neurobehavioral/metabolic source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review.

On this page, this source examines Endocannabinoids activity involving CB1. 1

Study type
narrative or expert review
Population or model
people or patients
Outcome focus
cB1 neurobehavioral, appetite, metabolic, pain, cognition, or synaptic mechanisms
Evidence stage
evidence still limited

narrative or expert review

New Insights in Cannabinoid Receptor Structure and Signaling.

On this page, this source examines Cannabinoids activity involving CB1. 2

Study type
narrative or expert review
Outcome focus
cB1 neurobehavioral, appetite, metabolic, pain, cognition, or synaptic mechanisms
Evidence stage
evidence still limited

animal study

CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a.

On this page, this source examines Cannabinoids activity involving CB1. 3

Study type
animal study
Population or model
animal models
Outcome focus
cB1 neurobehavioral, appetite, metabolic, pain, cognition, or synaptic mechanisms
Evidence stage
mechanism-focused research

systematic review or meta-analysis

The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.

On this page, this source examines THC activity involving CB1. 4

Study type
systematic review or meta-analysis
Population or model
people or patients
Outcome focus
cB1 neurobehavioral, appetite, metabolic, pain, cognition, or synaptic mechanisms
Evidence stage
evidence still limited

clinical study in people

Cross state-dependent memory retrieval between cannabinoid CB1 and serotonergic 5-HT1A receptor agonists in the mouse dorsal hippocampus.

On this page, this source examines Cannabinoids activity involving CB1. 5

Study type
clinical study in people
Population or model
people or patients
Outcome focus
cB1 neurobehavioral, appetite, metabolic, pain, cognition, or synaptic mechanisms
Evidence stage
mechanism-focused research

Safety and limits

What should readers keep in mind?

Research on CB1 receptor neurobehavioral/metabolic should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects CB1 receptor biology with neurobehavioral, reward, appetite, metabolic, pain, or cognition-related mechanisms?

Relevant research is collected here. Most of the current evidence is preclinical or focused on biological mechanisms. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review. narrative or expert review; evidence still limited PubMed 34050525 DOI 10.1007/s43440-021-00270-y
  2. 2
    New Insights in Cannabinoid Receptor Structure and Signaling. narrative or expert review; evidence still limited PubMed 30767756 DOI 10.2174/1874467212666190215112036
  3. 3
    CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a. animal study; mechanism-focused research PubMed 17895407 DOI 10.1124/mol.107.039263
  4. 4
    The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species. systematic review or meta-analysis; evidence still limited PubMed 31165913 DOI 10.1007/s00213-019-05283-3
  5. 5
    Cross state-dependent memory retrieval between cannabinoid CB1 and serotonergic 5-HT1A receptor agonists in the mouse dorsal hippocampus. clinical study in people; mechanism-focused research PubMed 35595026 DOI 10.1016/j.nlm.2022.107638
  6. 6
    Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities. narrative or expert review; evidence still limited PubMed 31771126 DOI 10.3390/ijms20235874
  7. 7
    Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice. narrative or expert review; evidence still limited PubMed 16596773 DOI 10.1007/3-540-26573-2_4
  8. 8
    Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse. narrative or expert review; evidence still limited PubMed 25967266 DOI 10.1016/j.neuroscience.2015.05.002
  9. 9
    Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery? narrative or expert review; evidence still limited PubMed 20590557 DOI 10.1111/j.1476-5381.2010.00777.x
  10. 10
    Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. narrative or expert review; evidence still limited PubMed 19285266 DOI 10.1016/j.beem.2008.09.003
  11. 11
    Endocannabinoid System: A Multi-Facet Therapeutic Target. narrative or expert review; evidence still limited PubMed 27086601 DOI 10.2174/1574884711666160418105339
  12. 12
    Latest advances in cannabinoid receptor agonists. narrative or expert review; evidence still limited PubMed 19939187 DOI 10.1517/13543770903436505
See all 24 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. New Insights in Cannabinoid Receptor Structure and Signaling. narrative or expert review; evidence still limited / 1 linked research note PubMed 30767756
  2. Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities. narrative or expert review; evidence still limited / 1 linked research note PubMed 28527758
  3. Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery? narrative or expert review; evidence still limited / 1 linked research note PubMed 20590557
  4. Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review. narrative or expert review; evidence still limited / 1 linked research note PubMed 34050525
  5. Endocannabinoid System: A Multi-Facet Therapeutic Target. narrative or expert review; evidence still limited / 1 linked research note PubMed 27086601
  6. CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a. animal study; mechanism-focused research / 1 linked research note PubMed 17895407
  7. Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities. narrative or expert review; evidence still limited / 1 linked research note PubMed 31771126
  8. The pharmacology of cannabinoid receptors and their ligands: an overview. narrative or expert review; evidence still limited / 1 linked research note PubMed 16570099
  9. Latest advances in cannabinoid receptor agonists. narrative or expert review; evidence still limited / 1 linked research note PubMed 19939187
  10. Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. narrative or expert review; evidence still limited / 1 linked research note PubMed 19285266
  11. Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications. narrative or expert review; evidence still limited / 1 linked research note PubMed 31461639
  12. The endocannabinoid system: physiology and pharmacology. narrative or expert review; evidence still limited / 1 linked research note PubMed 15550444
  13. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism. animal study; mechanism-focused research / 1 linked research note PubMed 36088492
  14. Role of the cannabinoid CB1 receptor in methamphetamine-induced social and recognition memory impairment. animal study; mechanism-focused research / 1 linked research note PubMed 35429587
  15. Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models. animal study; mechanism-focused research / 1 linked research note PubMed 40855505
  16. Adipocyte cannabinoid CB1 receptor deficiency alleviates high fat diet-induced memory deficit, depressive-like behavior, neuroinflammation and impairment in adult neurogenesis. animal study; mechanism-focused research / 1 linked research note PubMed 31491589
  17. Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse. narrative or expert review; evidence still limited / 1 linked research note PubMed 25967266
  18. A cannabinoid link between mitochondria and memory. animal study; mechanism-focused research / 1 linked research note PubMed 27828947
  19. Pharmacological inhibition of the CB1 cannabinoid receptor restores abnormal brain mitochondrial CB1 receptor expression and rescues bioenergetic and cognitive defects in a female mouse model of Rett syndrome. animal study; mechanism-focused research / 1 linked research note PubMed 39300547
  20. The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 31165913
  21. Cross state-dependent memory retrieval between cannabinoid CB1 and serotonergic 5-HT1A receptor agonists in the mouse dorsal hippocampus. clinical study in people; mechanism-focused research / 1 linked research note PubMed 35595026
  22. Adenosine receptors are the on-and-off switch of astrocytic cannabinoid type 1 (CB1) receptor effect upon synaptic plasticity in the medial prefrontal cortex. animal study; mechanism-focused research / 1 linked research note PubMed 38482984
  23. Hippocampal Deletion of CB1 Receptor Impairs Social Memory and Leads to Age-Related Changes in the Hippocampus of Adult Mice. animal study; mechanism-focused research / 1 linked research note PubMed 36613469
  24. Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice. narrative or expert review; evidence still limited / 1 linked research note PubMed 16596773